John Overdeck’s General Moly, Inc. GMO Stock Holding History

John Overdeck’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-31,250	Closed	-$42K	–	2368
2013 Q4	$42K	Buy	+31,250	New	+$44.9K	﹤0.01%	2127

Other funds holding GMO

CCM

Coghill Capital Management Chicago, Illinois $3.63M AUM 18.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

John Overdeck's GMO Position: Q1 2014 in Review

John Overdeck sold out of General Moly, Inc. (GMO) in Q1 2014, closing a stake of 31,250 shares — an estimated $42K sold.

John Overdeck first reported a position in GMO in Q4 2013 and held it in 1 quarter. The position peaked at $42K in Q4 2013. 59 funds tracked by Wall St. Rank hold GMO as of Q1 2014.

John Overdeck reported no remaining General Moly, Inc. position as of Q1 2014 after selling out during the quarter.
John Overdeck sold 31,250 General Moly, Inc. shares in Q1 2014, an estimated $42K.
John Overdeck first reported a position in General Moly, Inc. in Q4 2013 and held it in 1 quarter.
John Overdeck's General Moly, Inc. position peaked at $42K in Q4 2013.
59 funds tracked by Wall St. Rank held General Moly, Inc. as of Q1 2014.

Based on Two Sigma Investments's 13F filing for Q1 2014, filed 15 May 2014.